Zou Jieru, Yuan Jie, Liu Jingjin, Geng Qingshan
The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
Department of Cardiology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Front Cardiovasc Med. 2023 Dec 13;10:1164104. doi: 10.3389/fcvm.2023.1164104. eCollection 2023.
Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels. Indeed, among high-risk patients, TAVR outcomes are comparable to, or even better, than that of the traditional surgical aortic valve replacement (SAVR) method. TAVR outcomes, with respect to post-surgical functional capacity and quality of life, have also been found to be improved, especially when combined with cardiac rehabilitation (CR). CR is a multidisciplinary system, which integrates cardiology with other medical disciplines, such as sports, nutritional, mind-body, and behavioral medicine. It entails the development of appropriate medication, exercise, and diet prescriptions, along with providing psychological support, ensuring the cessation of smoking, and developing risk factor management strategies for cardiovascular disease patients. However, even with CR being able to improve TAVR outcomes and reduce post-surgical mortality rates, it still has largely been underutilized in clinical settings. This article reviews the usage of CR during both pre-and postoperative periods for valvular diseases, and the factors involved in influencing subsequent patient prognoses, thereby providing a direction for subsequent research and clinical applications.
经导管主动脉瓣置换术（TAVR）是一种相对较新的治疗主动脉瓣狭窄（AS）的方法，已被证明适用于不同风险水平的患者。事实上，在高危患者中，TAVR的治疗效果与传统外科主动脉瓣置换术（SAVR）相当，甚至更好。在术后功能能力和生活质量方面，TAVR的治疗效果也有所改善，尤其是与心脏康复（CR）相结合时。CR是一个多学科体系，它将心脏病学与其他医学学科整合在一起，如运动、营养、身心和行为医学。它需要制定适当的药物、运动和饮食处方，同时提供心理支持，确保戒烟，并为心血管疾病患者制定危险因素管理策略。然而，尽管CR能够改善TAVR的治疗效果并降低术后死亡率，但在临床环境中其应用仍严重不足。本文回顾了CR在瓣膜疾病术前和术后的使用情况，以及影响患者后续预后的因素，从而为后续研究和临床应用提供方向。
